Researcher
Katrien Lagrou
- Disciplines:Microbiology, Public health care
Affiliations
- Department of Microbiology, Immunology and Transplantation (Department)
Responsible
From1 Aug 2020 → Today - Laboratory of Clinical Microbiology (Division)
Responsible
From1 Feb 2017 → Today - Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2003 → Today - Laboratory of Molecular Bacteriology (Rega Institute) (Division)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 18
- Insights in febrile neutropenia (SAFE study) and clinical and translational insights in (invasive) mold infections and mycology, with the focus on Hematologic patients.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- MucorVax – Development of a first-in-class fungal vaccine candidateFrom1 Oct 2023 → TodayFunding: IOF - technology concept exploration
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Dynamics of the Type 3 secretion system translocase(DOT3S)From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- PhD on the epidemiology of invasive pneumococcal diseaseFrom25 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Multimodal dual-imaging-derived biomarkers for unravelling host response from lung disease progression in cystic lung fibrosis, infection and therapyFrom15 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patientsFrom14 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Unravelling the pathogenic mechanism behind influenza associated aspergillosisFrom25 Sep 2019 → TodayFunding: FWO fellowships
Publications
31 - 40 of 332
- Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid(2022)
Authors: Toine Mercier, Katrien Lagrou, Johan Maertens
- Quantitative PCR Effectively Quantifies Triazole-Susceptible and Triazole-Resistant Aspergillus fumigatus in Mixed Infections(2022)
Authors: Agustin Reséndiz Sharpe, Wannes Van Holm, Wim Teughels, Katrien Lagrou, Greetje Vande Velde
- Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study(2022)
Authors: Ruth Van Daele, Joost Wauters, Omar Elkayal, Erwin Dreesen, Yves Debaveye, Katrien Lagrou, Johan Maertens
- Child Neurology: Familial Hemophagocytic Lymphohistiocytosis Underlying Isolated CNS Inflammation.(2022)
Authors: Giorgia Bucciol, Xavier Bossuyt, Katrien Lagrou, Katrien Jansen, Liesbeth De Waele, Isabelle Meyts
Pages: 660 - 664 - Child Neurology: Familial Hemophagocytic Lymphohistiocytosis Underlying Isolated CNS Inflammation(2022)
Authors: Giorgia Bucciol, Xavier Bossuyt, Katrien Lagrou, Katrien Jansen, Liesbeth De Waele, Isabelle Meyts
Pages: 660 - 664 - Impact of COVID-19 on viral respiratory infection epidemiology in young children: A single-center analysis(2022)
Authors: François Vermeulen, Anne Debeer, Katrien Lagrou, Anne Smits
- Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review(2022)
Authors: Agustin Reséndiz Sharpe, Katrien Lagrou
- Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies(2022)
Authors: Louis Nevejan, Lize Cuypers, Lies Laenen, Liselotte Van Loo, François Vermeulen, Stefanie Desmet, Katrien Lagrou, Piet Maes, Emmanuel Andre
Pages: 1729 - 1731 - MAVS Expression in Alveolar Macrophages Is Essential for Host Resistance against Aspergillus fumigatus(2022)
Authors: Katrien Lagrou, Johan Maertens
Pages: 346 - 353 - The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries(2022)
Authors: Katrien Lagrou
Pages: E543 - E552